Anavex Life Sciences Corp. shares rocketed over 27% on Monday, hitting their highest levels since February 2023, fueled by a ...

Study to assess ability of GAL-101 eye drops in slowing or stopping the growth of geographic atrophy, a severe form of age-related macular ...

In their valuable study, Lee et al. explore a role for the Hippo signaling pathway, specifically wts-1/LATS and the downstream regulator yap, in age-dependent neurodegeneration and microtubule ...

Company to host a webcasttoday at 8:30 a.m. Eastern TimeNEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the ...

The U.S. Preventive Services Task Force released a draft recommendation advising against using vitamin D to prevent falls and ...

Glyceryl trinitrate (GTN), also known as nitroglycerin, is predominantly recognized as a vasodilator for ischemic heart disease, and its potential neuroprotective properties in acute ischemic stroke ...

Menopause, marked by declining oestrogen, may increase Alzheimer's risk in women. Oestrogen's neuroprotective role diminishes ...

6-8, 2024, in Montreal, Canada. “The preclinical data presented demonstrate for the first time the neuroprotective effects of ATH-1105 in human models of ALS, including human iPSC-derived motor ...

Alzheimer's disease, prevalent in older adults, may become more likely in women due to hormonal changes from menopause and ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer's disease.

The phase 2 SHIMMER trial enrolled 130 patients with dementia with Lewy bodies who received either a 100-mg or a 300-mg dose ...